Researchers identify cancer-causing gene in many colon cancers

September 15, 2008

BOSTON--Demonstrating that despite the large number of cancer-causing genes already identified, many more remain to be found, scientists at Dana-Farber Cancer Institute have linked a previously unsuspected gene, CDK8, to colon cancer.

The discovery of CDK8's role in cancer was made possible by new tools for assessing the activity of specific genes, say the authors of the new study. As these tools are further improved, the stream of newly discovered cancer genes is expected to increase, providing new avenues for therapy, the authors suggest. The findings are being published as an advanced online publication by the journal Nature on Sept. 14.

"This study provides confirmation that many of the genes involved in cancer have yet to be identified," remarked the study's senior author, William Hahn, MD, PhD, of Dana-Farber and the Broad Institute of Harvard and M.I.T. "When it comes to identifying gene targets for therapy, we've really only scratched the surface."

The study is noteworthy in another respect, as well, the authors indicated. Many of the abnormal proteins linked to cancer are known as "transcription factors" because they're able to "read" cell DNA and use that information for producing other cell proteins. Although transcription factors are important regulators, this class of proteins has proven to be impossible to target with drugs. Genes that influence such transcription factors, however, make attractive targets for drugs, since they can potentially disrupt the cancer process and disable tumor cells. CDK8 is such a gene.

The new study began with a focus on a protein called beta-catenin, a transcription factor that is overactive in nearly all colorectal cancers. Although overactive beta-catenin plays a role in the initial formation of tumors, other genetic abnormalities must occur for tumors to become fully malignant.

To determine which genes control the production of beta-catenin and are involved in the proliferation of colon cancer cells, the research team ran three screening tests. In the first two, they used RNA interference to shut down more than a thousand genes one by one and recorded the instances where beta-catenin activity decreased and the cells stopped growing. They then analyzed colon cancers for genes that had extra copies. When they examined where the results of the three tests overlapped, one gene stood out -- CDK8, explained Hahn, who is also an associate professor of medicine at Harvard Medical School

The protein produced from CDK8 is part of the "mediator complex," a conglomeration of proteins that serves as a bridge for compounds involved in gene transcription. "This study demonstrates that blocking CDK8 interferes with the proliferation of colon cancer cells that have high levels of the CDK8 protein and overactive beta-catenin," Hahn said. "Drugs that target CDK8 may be very useful against tumors whose growth is driven by beta-catenin."

Dana-Farber Cancer Institute

---

---

	Beta-Catenin: Webster's Timeline History, 1992 - 2007 by Icon Group International (Author) Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Beta-Catenin," including when used in literature (e.g. all authors that might have Beta-Catenin in their name). As such, this book represents the largest compilation of timeline events associated with Beta-Catenin when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage. These furthermore cover all parts of speech (possessive, institutional usage, geographic usage) and contexts, including pop culture, the arts, social...
	$ beta$-Catenin and Ha-ras - Master Regulators of Zonal Gene Expression in Mouse Liver? by Albert Braeuning (Author)
	Citrus flavanone naringenin enhances melanogenesis through the activation of Wnt/[beta] -catenin signalling in mouse melanoma cells.(Report): An ... Journal of Phytotherapy & Phytopharmacology by Huang Yu-Chun (Author), Yang Chao-Hsun (Author), Chiou Yi-Ling (Author)
	Beta-catenin stabilization extends regulatory T cell survival and induces anergy in non-regulatory T cells. by Yi Ding (Author) In this dissertation I focus on the effect of beta-catenin on the function of regulatory T cells and non-regulatory T cells. beta-catenin is the key mediator of the canonical Wnt pathway, which is evolutionarily conserved and involved in a large variety of developmental process, including cell proliferation and cell fate decisions. Expression of a stable form of beta-catenin on CD4+CD25+ regulatory T cells (Tregs) resulted in a striking enhancement of survival of these cells in vitro. Furthermore, stable beta-catenin-expressing CD4+CD25+ Tregs out competed control Tregs in vivo, and the number of Tregs necessary for protection against inflammatory bowel disease (IBD) could be substantially reduced when stable beta-catenin-expressing CD4+CD25+ Tregs were used instead of control Tregs....
	D-DT-dependent regulation of COX-2 expression by beta-catenin and JNK/c-Jun-dependent pathways. by Dan Xin (Author) The small cytokine/growth factor, migration inhibitory factor (MIF) is a central participant in pro-growth and metastatic tumor processes. To date, there is only one other known MIF family member, D-dopachrome tautomerase (D-DT). Despite the increasingly accepted importance of MIF in cancer progression and disease severity, very little work has been done to investigate what the biological function of this MIF family member is. We now report that D-DT regulates COX-2 expression via both stabilized beta-catenin and a JNK/c-Jun-dependent pathway in human adenocarcinoma cells. Additionally, our studies indicate that D-DT depletion by siRNA strongly increases tumor suppressor p53 protein levels and transcriptional activity. Interestingly, MIF depletion by siRNA results in a corresponding...
	beta-catenin, TCF, and ICAT in T cell development, function, and aging. by Mohammad Zulfiquer Hossain (Author) Both T cell factor (TCF) and beta-catenin play important roles during different stages of T cell development. Most strikingly, deletion of TCF results in a block early in development, which becomes complete with TCF-LEF double deletion. Similarly, T-cell specific deletion of beta-catenin impairs T cell development at the beta-selection checkpoint. However, in addition to working together to drive expression of beta-catenin-TCF target genes, both TCF and beta-catenin have the potential to work independently of each other. To specifically study the role of beta-catenin-TCF interactions during T cell development, function, and aging, we generated transgenic mice that express ICAT, a naturally occurring inhibitor of beta-catenin-TCF interactions, in the T cell lineage. We found that...
	Critical roles of Wnt/beta-catenin signaling during development of the retinal pigment epithelium. by Peter D Westenskow (Author) The RPE is a polarized pigmented epithelial monolayer that is critical for vision and development of the neural retina. Considering its diverse and required roles, it is surprising how little is known about how it develops. Two transcription factors Mitf and Otx2 have been identified. Both are required for RPE development by activating many RPE terminal differentiation genes. The loss of either factor is catastrophic and induces RPE cells to dedifferentiate and to instead express retina-specific genes in a process termed RPE-to-retina transdifferentiation. Therefore, it is imperative that Mitf and Otx2 expression levels be maintained during development. A few other intrinsic and extrinsic factors have been identified that regulate RPE fate, but only one gene family (Pax genes) has been...
	Chemical-genetic screening identifies novel protein regulators of Wnt/beta-catenin signaling. by Travis Logan Biechele (Author) Wnt/beta-catenin signaling regulates many aspects of metazoan development and adult homeostasis. Aberrant Wnt signaling has been linked to numerous pathological conditions. A thorough understanding of the Wnt/beta-catenin signal transduction events is crucial to the development of therapies that may be therapeutic in these pathological conditions. In the last few years, high-throughput screening of both chemicals and siRNAs has identified several novel protein regulators of Wnt/beta-catenin signaling. The research outlined in this dissertation describes the construction and characterization of a robust reporter of Wnt/beta-catenin signaling and its application in both high-throughput small molecule and siRNA screens to identify, Bruton's tyrosine kinase (BTK), metabotropic glutamate...
	Preferential activation of beta-catenin nuclear signaling in atherosclerosis susceptible vasculature and contributions to atherogenic gene expression. by Bradley David Unti Gelfand (Author) Shear stress represents a major contributor to vascular endothelial cell phenotype. The development of atherosclerosis tends to occur in vascular beds associated with low and reversing shear stress (atheroprone). In contrast, vascular beds exposed to relatively high and unidirectional shear stress tend to be resistant to atherosclerosis (atheroprotective). The identification of signaling pathways associated with atherogenic phenotypes presents an opportunity for the therapeutic intervention of a global health problem. To study the effect of regional hemodynamics on endothelial cell biology, a quantitative description of the forces present in the human body is required. Phase-contrast magnetic resonance imaging was used in order to measure shear stress in the carotid bifurcation. A new...
	Targeting the BCL9/B9L binding interaction with beta-catenin as a potential anticancer strategy. by Steven Akira Kawamoto (Author) Wnt signaling plays a critical role in numerous cellular processes including embryonic development, cell proliferation and tissue homeostasis. The multifunctional protein beta-catenin is the primary mediator of canonical Wnt signaling and acts as a transcriptional activator in this context. Dysregulated Wnt signaling is a hallmark of many human cancers and results in the stabilization and accumulation of beta-catenin, leading to the increased transcription and expression of Wnt target genes. The transcriptional activation function of beta-catenin requires the formation of a nuclear super-complex with protein cofactors including BCL9/B9L, TCF and CBP. It has been demonstrated that binding to these cofactors is essential for transcriptional. Of these critical cofactors, BCL9 and its homolog...